comparemela.com

Latest Breaking News On - ஃபைசர் இன்க் அல்லது மாடர்னா - Page 5 : comparemela.com

COVID SCIENCE-Drugs, vaccines less effective vs new virus variants; antibody cocktail may protect patients contacts

COVID SCIENCE-Drugs, vaccines less effective vs new virus variants; antibody cocktail may protect patients contacts Reuters 1/27/2021 By Nancy Lapid Jan 27 (Reuters) - The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Coronavirus variants escape effects of antibody drugs Antibody therapies and vaccines for treating or preventing COVID-19 are likely to be less effective against some of the new variants of the coronavirus circulating around the world, a new study suggests. Of particular concern is the variant identified in South Africa and another one first found in Brazil with similar features. In lab tests, Eli Lilly and Co s antibody bamlanivimab was inactive against the South Africa strain, according to a report posted on Tuesday on bioRxiv ahead of peer review. The drug just last week had shown an ability to cut the risk of COVID-19 by 80%

Drugs, vaccines less effective vs new virus variants; antibody cocktail may protect patients contacts

The coronavirus disease (COVID-19) outbreak in Oldham (Reuters) – The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus. Coronavirus variants escape effects of antibody drugs Antibody therapies and vaccines for treating or preventing COVID-19 are likely to be less effective against some of the new variants of the coronavirus circulating around the world, a new study suggests. Of particular concern is the variant identified in South Africa and another one first found in Brazil with similar features. In lab tests, Eli Lilly and Co’s antibody bamlanivimab was inactive against the South Africa strain, according to a report posted on Tuesday on bioRxiv ahead of peer review. The drug just last week had shown an ability to cut the risk of COVID-19 by 80% for nursing home residents. The activity of one antibody in Regeneron Pharmaceuticals Inc’s dual-a

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.